Document is current

Oral paricalcitol: expanding therapeutic options for pediatric chronic kidney disease patients

Crossref DOI link: https://doi.org/10.1007/s00467-017-3675-7

Published Online: 2017-04-27

Published Print: 2017-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy